missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies 3-Deazaneplanocin A
Epigenetic modifier; Inhibits histone EZH2 lysine methyltransferase
Marke: STEMCELL Technologies 72322
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
- Deazaneplanocin A (DZNep) is an inhibitor of lysine methyltransferases, particularly EZH2
- DZNep therefore acts as an epigenetic modifier, specifically inhibiting the trimethylation of Histone 3, Lysine 27, by depleting levels of EZH2
- (Miranda et al.), Tan et al.), Tseng et al.)
- Enables chemical reprogramming (without genetic factors) of mouse embryonic fibroblasts to induced pluripotent stem (iPS) cells, in combination with CHIR99021, Forskolin, VaLproic Acid, Tranylcypromine, and E-616452, by increasing OCT4 expression at later stages of reprogramming (Hou et al.)
- Reactivation of XIST-dependent inactive X chromosomes in human embryonic stem cells (Diaz Perez et al.)
- Inhibits self-renewal of glioblastoma multiforme cancer stem cells (Suva et al.)
- Inhibits survival of acute myeloid leukemia blast cells, in combination with a histone deacetylase inhibitor (Fiskus et al.)
Spezifikation
| 102052-95-9 | |
| 500 μg | |
| ≥97% |
| DZNep; NSC 617989 | |
| C12H14N4O3 |